FDA rejects rare disease therapy from Disc Medicine, early recipient of commissioner’s voucher Agency expedited review of blood disorder therapy as part of new program

https://www.statnews.com/2026/02/13/disc-medicine-fda-decision/ By Lizzy Lawrence and Adam FeuersteinFeb. 13, 2026